New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
07:29 EDTDRNA, ZIOP, EBIO, RGDO, ESPR, KBIO, OMER, ATNM, TGTX, HZNP, FPRXBioCentury to hold a conference
Future Leaders in the Biotech Industry Conference is being held in New York on March 28.
News For ATNM;RGDO;FPRX;OMER;EBIO;HZNP;KBIO;ZIOP;TGTX;ESPR;DRNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
08:18 EDTESPREsperion has a conference call hosted by JPMorgan
Subscribe for More Information
07:03 EDTHZNPHorizon Pharma announces USPTO issuance of Notice of Allowance
Subscribe for More Information
July 1, 2015
07:22 EDTDRNADicerna reports inducement grants to purchase 115,500 shares
Subscribe for More Information
June 30, 2015
09:26 EDTZIOPOn The Fly: Pre-market Movers
Subscribe for More Information
June 29, 2015
14:58 EDTESPRViking Global reports 5.9% passive stake in Esperion
Subscribe for More Information
June 26, 2015
07:28 EDTHZNPHorizon Pharma price target raised to $40 from $32 at UBS
Subscribe for More Information
June 25, 2015
10:00 EDTESPROn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:34 EDTEBIOAegerion appoints Eleven Biotherapeutics CFO Gregory Perry as CFO
Subscribe for More Information
06:36 EDTESPREsperion initiated with an Overweight at JPMorgan
Subscribe for More Information
June 24, 2015
10:00 EDTESPROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Sell from Neutral at Goldman... Catamaran (CTRX) downgraded to Neutral from Buy at UBS... Citi (C) downgraded to Hold from Buy at Deutsche Bank... Esperion (ESPR) downgraded to Neutral from Outperform at Credit Suisse... Fortinet (FTNT) downgraded to Neutral from Buy at Citi... General Motors (GM) downgraded to Neutral from Buy at Goldman... Goldman Sachs (GS) downgraded to Hold from Buy at Deutsche Bank... IBERIABANK (IBKC) downgraded to Neutral from Outperform at Baird... Independent Bank (INDB) downgraded to Underperform from Neutral at Baird... Inphi (IPHI) downgraded to Market Perform from Outperform at Northland... MoneyGram (MGI) downgraded to Neutral from Outperform at Macquarie... Sensata (ST) downgraded to Hold from Buy at Cross Research... Teradyne (TER) downgraded to Buy from Conviction Buy at Goldman... Alcobra (ADHD) downgraded to Hold from Speculative Buy at WBB Securities.
07:25 EDTESPREsperion risk/reward favorable following pullback, says UBS
Subscribe for More Information
07:01 EDTESPREsperion downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse assumed coverage on Esperion with a Neutral rating from an Outperform rating and lowered its price target to $86 from $130. The analyst would like to see more visibility on the upcoming FDA decision and product labels for PCSK9s, output of End of Phase 2 FDA meeting with the FDA in August, and clarity on the mechanism of action for ETC-1002 before recommending shares.
June 23, 2015
07:36 EDTKBIO, HZNPJMP Securities to hold a conference
Subscribe for More Information
07:12 EDTHZNPHorizon Pharma announces notice of allowance with claims covering Ravicti
Horizon Pharma announced that it has received from the United States Patent and Trademark Office a Notice of Allowance for U.S. patent application number 13/775,000, entitled "Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs" that covers Horizon's U.S. approved product Ravicti Oral Liquid.
June 22, 2015
10:00 EDTZIOPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:14 EDTZIOPOn The Fly: Pre-market Movers
Subscribe for More Information
07:59 EDTZIOPZiopharm downgraded on valuation, competition at BMO Capital
As noted earlier, BMO Capital downgraded Ziopharm Market Perform from Outperform. As reasons for the downgrade, the firm cited valuation, increased competition, and its belief that the company has fallen further behind its competitors. Target to $10 from $15.
06:29 EDTZIOPZiopharm downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use